Literature DB >> 12137930

Kappa-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex.

Adena L Svingos1, Eric E O Colago.   

Abstract

Activation of kappa-opioid receptors (KOR) in the medial prefrontal cortex (mPFC) modulates excitatory transmission, which may involve interactions with N-methyl-D-aspartate (NMDA) glutamate receptors. We investigated possible anatomical correlates of this modulation by using dual labeling electron microscopy to examine the cellular distributions of antibodies raised against KOR and the R1 subunit of the NMDA receptor (NR1). KOR immunoreactivity primarily was localized to plasma and vesicular membranes of axons and axon terminals that were morphologically heterogeneous. A small proportion of KOR immunoreactivity was associated with cytosolic compartments of dendrites and membranes of glial processes. NR1 labeling was mainly postsynaptic, associated most often with membranes of cytoplasmic organelles in cell bodies and large dendrites and plasmalemmal surfaces of distal dendrites. The remaining NR1-labeled profiles were axonal profiles and glial processes. Of all cellular associations between labeled profiles, the majority were KOR-labeled axons that contacted NR1-immunoreactive dendrites or cell bodies. Occasionally the two antigens were colocalized in axon terminals that formed either asymmetric synapses or displayed varicose morphology. KOR and NR1 also were colocalized within dendrites, and rarely were observed in the same cell bodies. Occasionally glial processes coursing adjacent to axo-spinous appositions expressed both KOR and NR1 immunoreactivity. These results indicate that ligand activation of KOR or NMDA receptors differentially modulates excitatory transmission in the mPFC through pre- and postsynaptic mechanisms, respectively. The data also suggest more minor roles for colocalized KOR and NMDA receptors in shared regulation of presynaptic transmitter release, postsynaptic responsivity, and glial function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12137930     DOI: 10.1016/s0006-8993(02)02894-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

Review 1.  The dynorphin/κ-opioid receptor system and its role in psychiatric disorders.

Authors:  H A Tejeda; T S Shippenberg; R Henriksson
Journal:  Cell Mol Life Sci       Date:  2011-10-16       Impact factor: 9.261

Review 2.  Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.

Authors:  Mark R Hutchinson; Yehuda Shavit; Peter M Grace; Kenner C Rice; Steven F Maier; Linda R Watkins
Journal:  Pharmacol Rev       Date:  2011-07-13       Impact factor: 25.468

Review 3.  Kappa-opioid ligands in the study and treatment of mood disorders.

Authors:  William A Carlezon; Cécile Béguin; Allison T Knoll; Bruce M Cohen
Journal:  Pharmacol Ther       Date:  2009-06-02       Impact factor: 12.310

4.  Prefrontal Cortical Kappa Opioid Receptors Attenuate Responses to Amygdala Inputs.

Authors:  Hugo A Tejeda; Ashley N Hanks; Liam Scott; Carlos Mejias-Aponte; Zoë A Hughes; Patricio O'Donnell
Journal:  Neuropsychopharmacology       Date:  2015-05-14       Impact factor: 7.853

5.  Stress-induced epigenetic regulation of κ-opioid receptor gene involves transcription factor c-Myc.

Authors:  Shlomit Flaisher-Grinberg; Shawna D Persaud; Horace H Loh; Li-Na Wei
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

6.  Prefrontal cortical kappa-opioid receptor modulation of local neurotransmission and conditioned place aversion.

Authors:  Hugo A Tejeda; Danielle S Counotte; Eric Oh; Sammanda Ramamoorthy; Kristin N Schultz-Kuszak; Cristina M Bäckman; Vladmir Chefer; Patricio O'Donnell; Toni S Shippenberg
Journal:  Neuropsychopharmacology       Date:  2013-03-29       Impact factor: 7.853

7.  Preliminary pharmacological evaluation of enantiomeric morphinans.

Authors:  Anna W Sromek; Brian A Provencher; Shayla Russell; Elena Chartoff; Brian I Knapp; Jean M Bidlack; John L Neumeyer
Journal:  ACS Chem Neurosci       Date:  2014-01-08       Impact factor: 4.418

8.  Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system.

Authors:  Arati Kreibich; Beverly A S Reyes; Andre L Curtis; Laurel Ecke; Charles Chavkin; Elisabeth J Van Bockstaele; Rita J Valentino
Journal:  J Neurosci       Date:  2008-06-18       Impact factor: 6.167

Review 9.  The locus coeruleus: A key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse.

Authors:  E J Van Bockstaele; B A S Reyes; R J Valentino
Journal:  Brain Res       Date:  2009-09-16       Impact factor: 3.252

10.  Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit.

Authors:  Nicole A Crowley; Daniel W Bloodgood; J Andrew Hardaway; Alexis M Kendra; Jordan G McCall; Ream Al-Hasani; Nora M McCall; Waylin Yu; Zachary L Schools; Michael J Krashes; Bradford B Lowell; Jennifer L Whistler; Michael R Bruchas; Thomas L Kash
Journal:  Cell Rep       Date:  2016-03-17       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.